Patents by Inventor David A. Meh

David A. Meh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for purifying antibodies using PBS
    Patent number: 10329323
    Abstract: Disclosed here includes a method for purifying a biologic composition, comprising diafiltering the biologic composition into a composition comprising phosphate buffered saline (PBS) to obtain a purified composition. The method disclosed here can be particularly useful for removing one or more impurities from the biologic composition, such as bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (Bis-tris).
    Type: Grant
    Filed: July 25, 2015
    Date of Patent: June 25, 2019
    Assignees: The United States of America, as represented by the Secretary, Department of Health & Human Services, United Therapeutics Corporation
    Inventors: Samir H. Shaban, Mary P. Koleck, David A. Meh, Gerald M. Farquharson, Timothy O. Atolagbe, George Mitra
  • METHOD FOR PURIFYING ANTIBODIES USING PBS
    Publication number: 20160185841
    Abstract: Disclosed here includes a method for purifying a biologic composition, comprising diafiltering the biologic composition into a composition comprising phosphate buffered saline (PBS) to obtain a purified composition. The method disclosed here can be particularly useful for removing one or more impurities from the biologic composition, such as bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (Bis-tris).
    Type: Application
    Filed: July 25, 2015
    Publication date: June 30, 2016
    Inventors: Samir H. Shaban, Mary P. Koleck, David A. Meh, Gerald M. Farquharson, Timothy O. Atolagbe, George Mitra
  • Thrombin inhibitor
    Patent number: 5985833
    Abstract: A thrombin inhibitor is disclosed. The thrombin inhibitor comprises: (1) a segment which inactivates or sequesters thrombin; (2) a segment comprising a portion of the fibrinogen .gamma.' chain that binds to the thrombin exosite, such as amino acid residues (414-427) and amino acid residues (414-425) of the native human fibrinogen .gamma.' sequence.
    Type: Grant
    Filed: September 17, 1996
    Date of Patent: November 16, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Michael W. Mosesson, David A. Meh